Subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist vs placebo/no treatment
Multiple pregnancy rate · women trying to conceive by intrauterine insemination
It is very uncertain whether subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist changes multiple pregnancy rate compared with placebo/no treatment (very low certainty).
1 finding from 1 review
- Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse 2022 · Cochrane Headline outcomes onlyRR 0.28 [0.11, 0.7]2 studies · 126 participantsVery low